Premium
Methaemoglobinaemia secondary to topical lignocaine/ prilocaine in a circumcised neonate
Author(s) -
Couper Rtl
Publication year - 2000
Publication title -
journal of paediatrics and child health
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.631
H-Index - 76
eISSN - 1440-1754
pISSN - 1034-4810
DOI - 10.1046/j.1440-1754.2000.00508.x
Subject(s) - medicine , prilocaine , methemoglobinemia , anesthesia , complication , pain relief , lidocaine , surgery
: The use of topical lignocaine/prilocaine (EMLA ® , Astra Pharmaceuticals, North Ryde, NSW, Australia) for pain relief for neonatal circumcision is becoming more prevalent. Because of immaturity of the methaemoglobin reductase pathway, the neonate is vulnerable to methaemoglobinaemia which is a recognized complication of prilocaine therapy. This is the second report of methaemoglobinaemia due to the use of EMLA ® in associateion with circumcision during the newborn period.